CBD treatment significantly reduced IDO and cGAS expression, correlating with decreased proinflammatory cytokines, including TNF-ฮฑ, IL-1ฮฒ, and IFN-ฮณ. These findings support CBD as a potential monotherapy or adjunctive treatment for AD by targeting distinct neuroinflammatory pathways.
Cannabis compounds could reverse disease affecting one-third of adults – Fox News
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchNeurologyCBD Dr. Caplan’s Take “What we’re seeing in the lab with cannabinoid reversal of neuroinflammation...
(โ)-ร-Caryophyllene, a Terpine Found in Cannabis, Demonstrates Therapeutic Potential in a Mouse Model of MS
(โ)-ฮฒ-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis In Summary Multiple sclerosis (MS) is a central nervous system disease whose inflammatory and other...